Albany Molecular Res (AMRI) 16.20 $AMRI Global Drug

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Albany Molecular Res (AMRI) 16.20 $AMRI

Global Drug Discovery Market Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: Infosys, Charles River Labs, Albany Molecular Research - Research and Markets
BusinessWire - Tue Sep 20, 6:49AM CDT
Research and Markets has announced the addition of the "Global Drug Discovery Market Analysis 2016 - Forecast to 2022" report to their offering.
AMRI: 16.20 (+0.03)

Lifshitz & Miller Law Firm Announces Investigation of Accuride Corporation, Albany Molecular Research Inc., Emergent BioSolutions, Inc., Flowers Foods, Inc., Orbital ATK, Inc., Quorum Health Corp., Stericycle, Inc., and SunPower Corporation
PR Newswire - Wed Sep 07, 3:06PM CDT
Accuride Corporation (ACW)
EBS: 28.36 (-0.38), ACW: 2.57 (+0.01), SRCL: 79.54 (+0.28), SPWR: 8.52 (+0.27), QHC: 6.28 (+0.03), OA: 74.44 (-0.33), AMRI: 16.20 (+0.03), FLO: 15.54 (-0.13)

AMRI CEO to Present at Morgan Stanley Global Healthcare Conference
PR Newswire - Tue Aug 30, 7:00AM CDT
Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 3:30 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2.
AMRI: 16.20 (+0.03), MS: 31.91 (-0.33)

AMRI CEO to Present at Baird 2016 Global Healthcare Conference
PR Newswire - Wed Aug 24, 7:00AM CDT
Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Baird 2016 Global Healthcare Conference on Wednesday, September 7, 2016 at 1:25 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2.
AMRI: 16.20 (+0.03)

AMRI Licenses CRISPR-Cas9 Gene Editing Technology
PR Newswire - Tue Aug 23, 3:05PM CDT
AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology and has completed several projects for its customers. The company will continue to use the technology to enhance its drug discovery service offerings and internal research and development. Financial terms were not disclosed.
AMRI: 16.20 (+0.03)

Update in Lawsuit for Investors in Albany Molecular Research, Inc. shares announced by Shareholders Foundation
GlobeNewswire - Tue Aug 23, 9:05AM CDT
The Shareholders Foundation, Inc. announces that a lawsuit is pending in New York on behalf of certain purchasers of shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) over alleged Securities Laws Violations by Albany Molecular Research.
AMRI: 16.20 (+0.03)

Ryan & Maniskas, LLP Announces Investigation of Albany Molecular Research Inc.
PR Newswire - Wed Aug 10, 5:00PM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Albany Molecular Research, Inc. ("Albany Molecular" or the "Company" (NASDAQ: AMRI).
AMRI: 16.20 (+0.03)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI)
PR Newswire - Tue Aug 09, 9:15AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Albany Molecular Research, Inc. ("Amri" or the "Company" (NASDAQ: AMRI). Such investors are advised to contact Peretz Bronstein or his investor relations analyst, Yael Hurwitz at info@bgandg.com or 212-697-6484.
AMRI: 16.20 (+0.03)

Robbins Arroyo LLP Is Investigating the Officers and Directors of Albany Molecular Research, Inc. (AMRI) on Behalf of Shareholders
BusinessWire - Mon Aug 08, 12:03PM CDT
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Albany Molecular Research, Inc. (NASDAQGS: AMRI) breached their fiduciary duties to the company and its shareholders by failing to implement adequate internal controls over the company's management and disclosure procedures. Albany Molecular Research, a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia.
AMRI: 16.20 (+0.03)

AMRI Announces Second Quarter 2016 Results
PR Newswire - Thu Aug 04, 6:30AM CDT
AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2016 and provided an update to its outlook for 2016.
AMRI: 16.20 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 30

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
Cuisine.K Brings Korean Seafood to Seattle Spotlight

Updated Category News Views 17

Korean Seafood Makes Waves in Seattle Bring out the chopsticks, ‘cause Korean seafood just took Seattle by storm with the Cuisine.K Korean culinary showcase. Hosted by CJ Foods, alongside the Korea Fisheries Association, this event smacked the local food scene square in the face with the unique flavors and techniques of K-Seafood—from students all the way to seasoned...

Continue Reading
Shorr Packaging's Sustainable Edge: EcoVadis Silver Triumph

Updated Category News Views 23

EcoVadis Silver Badge: Shorr's Green Path Imagine this: Shorr Packaging strutting around with an EcoVadis Silver Badge pinned to its chest for not one, not two, but three years now. That's right, Shorr Packaging's been elbowing its way to the top tier with their sustainability drive, ranked in the 93rd percentile. For those not keeping score, that's top-notch, considering...

Continue Reading
Avatar Capital Partners Secures $156M for Japan Focus

Updated Category News Views 74

A Strategic Partnership to Boost Fund II Avatar Capital Partners has nabbed $156 million for their Fund II, aiming at $300 million in Japan's living space. But the real kicker? They're now rubbing elbows with GCM Grosvenor and the Teacher Retirement System of Texas. Fancy way to say they've got some serious artillery now, with GCM Grosvenor and TRS throwing weight as...

Continue Reading
Adam Foundation's Ramadan Effort to Cut Plastic Waste

Updated Category News Views 50

Environmental Consciousness: A Call from Antalya Here we go again, folks. Something refreshing is brewing over in Antalya at COP31, where the UK-based Adam Foundation has made a move that resonates beyond the usual hubbub. No smoke and mirrors, just straightforward action aimed at cutting down the wave of plastic waste during Ramadan. This isn't some pie-in-the-sky green...

Continue Reading
Goldwin Teams Up with Centric for PLM Overhaul

Updated Category News Views 63

Solid Move or Risky Shift? Goldwin Inc., a well-regarded behemoth in Japan's outdoors market, is shaking things up and joining hands with Centric Software. We're looking at a modernization spree here, folks. The plan? Whip Goldwin's sprawling product data into shape with Centric PLM, a solution that promises a more structured product development approach. Streamlining,...

Continue Reading
Century Casinos Postpones Q3 2026 Earnings Call

Updated Category News Views 25

Century's Earnings Call Delay Rattles Investors Century Casinos, Inc. (NASDAQ: CNTY) just hit the pause button on its much-anticipated Q3 2026 earnings call, and let me tell you, this kind of move messes with investors' minds in ways numbers can't predict. Announcing they'll be filing an extension under Rule 12b-25, they've left the specifics hanging in the air, like an...

Continue Reading
Celebrating Ted Turner's Legacy at the United Nations

Updated Category News Views 14

Ted Turner's Unyielding Vision Celebrated at UN Gala Here we are, talking about Ted Turner, a guy who truly put his money where his mouth was. Not just another rich cat content with the status quo, he dropped a $1 billion bombshell in 1997 on the United Nations to shake up how the world's problems could be tackled. And last week, on November 9, notable bigwigs of the...

Continue Reading
TruGreen Finds New Growth in Birch Hill Acquisition

Updated Category News Views 47

TruGreen's New Chapter Begins In the world of lawn care, TruGreen is sowing the seeds for a revitalized future, courtesy of its recent acquisition by Birch Hill Equity Partners. Based out of Franklin, Tennessee, this powerhouse in the green arena is set to start a fresh chapter, swapping partners like old gloves after a long, 19-year stint with Clayton, Dubilier & Rice...

Continue Reading
Procon Uses Robotics to Revamp Cruise Terminal 5

Updated Category News Views 15

Building Bigger with Robotics at Port Canaveral Robots on a construction site sounds like sci-fi, right? But it's the reality at Port Canaveral's Cruise Terminal 5, where Procon is rolling out its robotic tech magic. This ain't your everyday wrench-and-spanner job; we're talking remote-controlled bots capturing 360-degree images. “Regular reality capture can help teams...

Continue Reading

Top 5 Most Recently Viewed Articles

RTI Surgical Enhances Portfolio with Collagen Solutions Buyout

Updated Category News Views 276

RTI Surgical Enhances Portfolio with Collagen Solutions Buyout RTI Surgical (RTI) has made a significant move in the regenerative medicine field by successfully acquiring Collagen Solutions, a distinguished supplier of engineered medical-grade collagen and xenograft tissue. This strategic acquisition was officially completed recently and is set to heighten RTI’s...

Continue Reading
Insights into SiteOne Landscape Supply's Changing Short Interest

Updated Category News Views 57

Understanding Short Interest in SiteOne Landscape Supply SiteOne Landscape Supply's short interest has captured the attention of investors and analysts alike, showing a notable decrease of 9.2% since the last report. Currently, the company reports 2.29 million shares sold short, which constitutes about 5.82% of the total regular shares available for trading. This figure...

Continue Reading
ARKO Corp. Scheduled to Release Q3 Financial Results Soon

Updated Category News Views 46

ARKO Corp. to Announce Third Quarter Financial Results In an interesting development, ARKO Corp. (Nasdaq: ARKO), a leading player in the convenience store sector in the United States, has announced that it will host a conference call focusing on its financial performance for the third quarter. This call is scheduled to take place soon. Event Details for the Financial Call...

Continue Reading
Kagurabachi's Anime Debut Electrifies Fans Globally

Updated Category News Views 52

The hype around Kagurabachi was palpable at the Anime Expo in Los Angeles, marking a memorable kickoff for its much-anticipated anime adaptation. For those in the know, this is a big deal—something akin to catching the first buzz of a hot stock before it rockets. With the convention center just buzzing, this wasn't just another day at the office, folks. Fans packed in...

Continue Reading
Heimar hf. Boosts Share Buybacks with Significant Acquisitions

Updated Category News Views 110

Heimar hf. Increases Ownership Through Strategic Buybacks During a recent trading week, Heimar hf. took proactive steps to enhance its market position by purchasing 4,000,000 of its own shares for a total of 134,600,000 ISK. This calculated move signals the company's commitment to maximizing shareholder value. Details of Recent Share Acquisitions Below is a summary of the...

Continue Reading